Treatment of intestinal conditions by a compound which causes RNA interference

Details for Australian Patent Application No. 2006224338 (hide)

Owner Sylentis S.A.U.

Inventors Gascon, Irene; Sesto, Angela; Jimenez, Ana I; Roman, Jose P.; Jimenez, Maria Concepcion

Agent Griffith Hack

Pub. Number AU-B-2006224338

PCT Pub. Number WO2006/097768

Priority 0505081.0 14.03.05 GB

Filing date 14 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 6 January 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/097768 Priority application(s): WO2006/097768

6 January 2011 Application Accepted

  Published as AU-B-2006224338

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224340-Treatment process for concrete

2006224336-Arylsulfonyl benzyl ethers as 5-HT2A antagonists